Sun, Cheminor to benefit from ‘Prozac’ ruling? - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  
  • Home
  • Outlook Arena
  • Aug 11, 2000 - Sun, Cheminor to benefit from ‘Prozac’ ruling?

Sun, Cheminor to benefit from ‘Prozac’ ruling?

Aug 11, 2000

With the court ruling that Eli Lilly’s ‘Prozac’ (bulk drug: fluoxetine hydrochloride) is to go off patent as early as August 2001 (as against August 2003) the first test of whether the USA generic market is as lucrative as has been made out to be, would be known. ‘Prozac’ is a $ 2.26 bn drug and once the drug goes generic, Eli Lilly can itself be expected to drop the prices of the drug by atleast 50%, if not more. However, this represents a good opportunity for companies such as Sun Pharma and Cheminor Drugs.

Sun Pharma is infact the only domestic company which is present in this segment. It derives 16.5% of its revenues from psychiatric drugs. The company however, refused to disclose whether it had filed an Abbreviated New Drug Application (ANDA) for anti–depressants in the USA as the company filing the patent would be its US subsidiary Caraco Industries and disclosure has yet to made to the American shareholders of Caraco.

The other company to benefit would of course be Cheminor Drugs (which is to be amalgamted into Dr. Reddy’s in the current year). Cheminor has reportedly filed for 10 mg, 20 mg and 40 mg dosages of fluoxetine hydrochloride.

A lot has been been made out about the Indian pharmaceutical companies abilities to tap the US generic market worth post 2003 with almost 36 blockbuster drugs going off patent. The market is estimated to said be worth around $ 32 bn almost five times the size of the domestic market. There have been articles and editorials recently to the effect that the Indian pharma companies have come of age. ‘Prozac’ promises to be an interesting test case.


Equitymaster requests your view! Post a comment on "Sun, Cheminor to benefit from ‘Prozac’ ruling?". Click here!

  

More Views on News

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Sep 23, 2020 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - PROCTER & GAMBLE HEALTH COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS